J Korean Med Assoc.  2015 Jan;58(1):49-54. 10.5124/jkma.2015.58.1.49.

Treatment of allergic diseases in elderly

• Ban GY
• Park HS

• KMID: 2149282
• DOI: http://doi.org/10.5124/jkma.2015.58.1.49

Abstract

The aged population is increasing worldwide, and it is therefore essential to identify the specific features of diseases in aged groups. The diagnosis of allergic diseases in the elderly is more difficult than in younger patients, because the differential diagnosis of other diseases must be excluded. The treatment of elderly allergic diseases is also challenging because most elderly patients have co-morbidities that affect the disease outcome. Co-morbidity is one of the most important factors to be considered when elderly allergic patients are treated. Co-morbidity and medications for co-morbidity affect allergic disease treatment in terms of drug-drug interaction, medication adherence, adverse drug reactions, and so on. Many studies of allergic diseases are focused on the younger population, while few studies have dealt with elderly allergic diseases. Further studies including diagnosis and treatment guidelines for elderly allergic disease are needed.

Keyword

Aged; Allergic disease; Therapeutics; Comorbidity

MeSH Terms

Aged*
Comorbidity
Diagnosis
Diagnosis, Differential
Drug-Related Side Effects and Adverse Reactions
Humans
Medication Adherence

Reference

1. Hanania NA, King MJ, Braman SS, Saltoun C, Wise RA, Enright P, Falsey AR, Mathur SK, Ramsdell JW, Rogers L, Stempel DA, Lima JJ, Fish JE, Wilson SR, Boyd C, Patel KV, Irvin CG, Yawn BP, Halm EA, Wasserman SI, Sands MF, Ershler WB, Ledford DK. Asthma in the elderly: current understanding and future research needs: a report of a National Institute on Aging (NIA) workshop. J Allergy Clin Immunol. 2011; 128:S4–S24.

2. Statistics Korea. Population projections [Internet]. Daejeon: Statistics Korea;2010. cited 2014 May 14. Available from: https://www.index.go.kr/egams/stts/jsp/potal/stts/PO_STTS_IdxMain.jsp?idx_cd=1010&bbs=INDX_001.

3. Kim S, Kim J, Kim K, Kim Y, Park Y, Baek S, Park SY, Yoon SY, Kwon HS, Cho YS, Kim TB, Moon HB. Healthcare use and prescription patterns associated with adult asthma in Korea: analysis of the NHI claims database. Allergy. 2013; 68:1435–1442.

4. Reed CE. Asthma in the elderly: diagnosis and management. J Allergy Clin Immunol. 2010; 126:681–687.

5. Global Initiative for Asthma. Global strategy for asthma management and prevention 2014 (revision) [Internet]. [place unknown]: Global Initiative for Asthma;2014. cited 2014 Sep 22. Available from: http://www.ginasthma.org/documents/4.

6. Hwang EK, Jin HJ, Nam YH, Shin YS, Ye YM, Nahm DH, Park HS. The predictors of poorly controlled asthma in elderly. Allergy Asthma Immunol Res. 2012; 4:270–276.

7. Park J, Kim TB, Joo H, Lee JS, Lee SD, Oh YM. Diseases concomitant with asthma in middle-aged and elderly subjects in Korea: a population-based study. Allergy Asthma Immunol Res. 2013; 5:16–25.

8. Ross JA, Yang Y, Song PX, Clark NM, Baptist AP. Quality of life, health care utilization, and control in older adults with asthma. J Allergy Clin Immunol Pract. 2013; 1:157–162.

9. Morales DR, Jackson C, Lipworth BJ, Donnan PT, Guthrie B. Adverse respiratory effect of acute β-blocker exposure in asthma: a systematic review and meta-analysis of randomized controlled trials. Chest. 2014; 145:779–786.

10. Enright PL. The diagnosis and management of asthma is much tougher in older patients. Curr Opin Allergy Clin Immunol. 2002; 2:175–181.

11. Bozek A, Warkocka-Szoltysek B, Filipowska-Gronska A, Jarzab J. Montelukast as an add-on therapy to inhaled corticosteroids in the treatment of severe asthma in elderly patients. J Asthma. 2012; 49:530–534.

12. Kang IJ, Kang HR, Ko YR, Ko YI, Ku JM, Kwon SS, Kwon YE, Kim KW, Kim KU, Kim KH. Asthma and allergic diseases. 2nd ed. Seoul: The Korean Academy of Asthma, Allergy and Clinical Immunology;2012.

13. Lee SM, Chang YS, Kim CW, Kim TB, Kim SH, Kwon YE, Lee JM, Lee SK, Jeong JW, Park JW, Cho SH, Moon HB, Jee YK. Skills in handling turbuhaler, diskus, and pressurized metered-dose inhaler in Korean asthmatic patients. Allergy Asthma Immunol Res. 2011; 3:46–52.

14. Nyenhuis SM, Mathur SK. Rhinitis in older adults. Curr Allergy Asthma Rep. 2013; 13:171–177.

15. Busse PJ, Kilaru K. Complexities of diagnosis and treatment of allergic respiratory disease in the elderly. Drugs Aging. 2009; 26:1–22.

16. Song WJ, Kim MY, Jo EJ, Kim MH, Kim TH, Kim SH, Kim KW, Cho SH, Min KU, Chang YS. Rhinitis in a community elderly population: relationships with age, atopy, and asthma. Ann Allergy Asthma Immunol. 2013; 111:347–351.

17. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica GW, van Weel C, Agache I, Aït-Khaled N, Bachert C, Blaiss MS, Bonini S, Boulet LP, Bousquet PJ, Camargos P, Carlsen KH, Chen Y, Custovic A, Dahl R, Demoly P, Douagui H, Durham SR, van Wijk RG, Kalayci O, Kaliner MA, Kim YY, Kowalski ML, Kuna P, Le LT, Lemiere C, Li J, Lockey RF, Mavale-Manuel S, Meltzer EO, Mohammad Y, Mullol J, Naclerio R, O'Hehir RE, Ohta K, Ouedraogo S, Palkonen S, Papadopoulos N, Passalacqua G, Pawankar R, Popov TA, Rabe KF, Rosado-Pinto J, Scadding GK, Simons FE, Toskala E, Valovirta E, van Cauwenberge P, Wang DY, Wickman M, Yawn BP, Yorgancioglu A, Yusuf OM, Zar H, Annesi-Maesano I, Bateman ED, Ben Kheder A, Boakye DA, Bouchard J, Burney P, Busse WW, Chan-Yeung M, Chavannes NH, Chuchalin A, Dolen WK, Emuzyte R, Grouse L, Humbert M, Jackson C, Johnston SL, Keith PK, Kemp JP, Klossek JM, Larenas-Linnemann D, Lipworth B, Malo JL, Marshall GD, Naspitz C, Nekam K, Niggemann B, Nizankowska-Mogilnicka E, Okamoto Y, Orru MP, Potter P, Price D, Stoloff SW, Vandenplas O, Viegi G, Williams D. World Health Organization; GA(2)LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008; 63:Suppl 86. 8–160.

18. Asero R. Efficacy of injection immunotherapy with ragweed and birch pollen in elderly patients. Int Arch Allergy Immunol. 2004; 135:332–335.

19. Bozek A, Ignasiak B, Filipowska B, Jarzab J. House dust mite sublingual immunotherapy: a double-blind, placebo-controlled study in elderly patients with allergic rhinitis. Clin Exp Allergy. 2013; 43:242–248.

20. Bozek A, Kolodziejczyk K, Warkocka-Szoltysek B, Jarzab J. Grass pollen sublingual immunotherapy: a double-blind, placebo-controlled study in elderly patients with seasonal allergic rhinitis. Am J Rhinol Allergy. 2014; 28:423–427.

21. Maurer M, Weller K, Bindslev-Jensen C, Gimenez-Arnau A, Bousquet PJ, Bousquet J, Canonica GW, Church MK, Godse KV, Grattan CE, Greaves MW, Hide M, Kalogeromitros D, Kaplan AP, Saini SS, Zhu XJ, Zuberbier T. Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report. Allergy. 2011; 66:317–330.

22. Magen E, Mishal J, Schlesinger M. Clinical and laboratory features of chronic idiopathic urticaria in the elderly. Int J Dermatol. 2013; 52:1387–1391.

23. Ventura MT, Napolitano S, Buquicchio R, Cecere R, Arsieni A. An approach to urticaria in the elderly patients. Immunopharmacol Immunotoxicol. 2012; 34:530–533.

24. Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C, Brzoza Z, Canonica GW, Church MK, Ensina LF, Gimenez-Arnau A, Godse K, Goncalo M, Grattan C, Hebert J, Hide M, Kaplan A, Kapp A, Abdul Latiff AH, Mathelier-Fusade P, Metz M, Nast A, Saini SS, Sanchez-Borges M, Schmid-Grendelmeier P, Simons FE, Staubach P, Sussman G, Toubi E, Vena GA, Wedi B, Zhu XJ, Maurer M. The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy. 2014; 69:868–887.

25. Staevska M, Gugutkova M, Lazarova C, Kralimarkova T, Dimitrov V, Zuberbier T, Church MK, Popov TA. Night-time sedating H1-antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial. Br J Dermatol. 2014; 171:148–154.